{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:26:02Z","timestamp":1791134762138,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.clinbiochem.2009.04.009","type":"journal-article","created":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T04:27:15Z","timestamp":1240460835000},"page":"1282-1290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or\/and duplication of the CYP2D6 gene"],"prefix":"10.1016","volume":"42","author":[{"given":"Borros","family":"Arneth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hiemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"H\u00e4rtter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2009.04.009_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1515\/CCLM.2003.087","article-title":"Pharmacogenetics of drug metabolizing enzymes: importance for personalised medicine","volume":"41","author":"Oscarson","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/clinchem\/43.2.254","article-title":"Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency","volume":"43","author":"Linder","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00008571-199606000-00001","article-title":"Nomenclature for human CYP2D6 alleles","volume":"6","author":"Daly","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib4","doi-asserted-by":"crossref","unstructured":"Nature genetics focus on structural genome variation July 2007;39:S1\u2013S54.","DOI":"10.1038\/ng0707s-S1"},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1098918","article-title":"Large-scale copy number polymorphism in the human genome","volume":"305","author":"Sebat","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng1416","article-title":"Detection of large-scale variation in the human genome","volume":"36","author":"Iafrate","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib7","first-page":"147","article-title":"Genetic polymorphism of CYP2D6","volume":"33","author":"Abraham","year":"2001","journal-title":"Indian. J. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/humu.10280","article-title":"CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR","volume":"22","author":"Schaeffeler","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00007691-200002000-00024","article-title":"Pharmacogenetic method as a complement to therapeutic monitoring of antidepressants and neuroleptics","volume":"22","author":"Dahl","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00008571-199610000-00005","article-title":"Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction","volume":"6","author":"St\u00fcven","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib11","first-page":"284","article-title":"Cytochrome P450 2D6 variants in a Caucasian population : allele frequencies and phenotypic consequences","volume":"60","author":"Sachse","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/clinchem\/46.8.1072","article-title":"Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR","volume":"46","author":"Hersberger","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib13","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1373\/49.10.1624","article-title":"Optimized strategy for rapid cytochrome P450 2D6 genotyping by real-time long PCR","volume":"49","author":"Muller","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0014-5793(96)00779-X","article-title":"Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene","volume":"392","author":"L\u00d8vlie","year":"1996","journal-title":"FEBS. Lett."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib15","first-page":"943","article-title":"Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of derisoquine\/sparteine polymorphism","volume":"48","author":"Gaedigk","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008571-199508000-00005","article-title":"Detection of the poor metabolizer-associated CYP2D6 (D) gene deletion allele by long-PCR technology","volume":"5","author":"Steen","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clinbiochem.2004.12.002","article-title":"Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN)","volume":"38","author":"Atanasova","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib18","series-title":"Cytochrome P450 2D6 deletion genotyping using derivative curve analysis on the LightCycler in Rapid cycle real-time PCR methods and applications quantification","first-page":"171","author":"Millson","year":"2004"},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib19","first-page":"3033","article-title":"Venlafaxine: a heterocyclic antidepressant","volume":"51","author":"Ellingrod","year":"1994","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2165\/00003495-199549020-00010","article-title":"Venlafaxine: a review of its pharmacology and therapeutic potential in depression","volume":"49","author":"Holliday","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-0447.1997.tb10136.x","article-title":"Efficacy of venlafaxine in depressive illness in general practice","volume":"95","author":"Lecrubier","year":"1997","journal-title":"Acta. Psychiatr. Scand."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib22","first-page":"G1","article-title":"Pharmakologie und Wirkungsmechanismmus von Venlafaxine","volume":"9","author":"Horst","year":"1998","journal-title":"Rev. Contemp. Pharmacother."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00007691-200004000-00011","article-title":"Venlafaxine serum levels and CYP2D6 genotype","volume":"22","author":"Veefkind","year":"2000","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib24","first-page":"83","article-title":"Venlafaxine-Eine neue Perspektive in der Depressionsbehandlung","volume":"10","author":"Murata","year":"1996","journal-title":"Fundam. Psychiatr."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ddr.430230210","article-title":"Biochemical, neurophysiological, and behavioural effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxine","author":"Muth","year":"1991","journal-title":"Drug. Dev. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2125.1996.tb00173.x","article-title":"Venlafaxine oxidation in-vitro is catalysed by CYP2D6","volume":"41","author":"Otton","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib27","first-page":"936","article-title":"Metabolism of venlafaxie: the role of P450 isoforms","volume":"35","author":"Fogelman","year":"1995","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0893-133X(98)00113-4","article-title":"O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from C DNA-transfected cells; effect of metabolic inhibitors and SSRI antidepressants","volume":"20","author":"Fogelman","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib29","first-page":"901","article-title":"An ascending single-dose tolerance study of Wy-45,030, a bicyclic antidepressant, in healthy men","volume":"42","author":"Fabre","year":"1987","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib30","first-page":"349","article-title":"Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite","volume":"23","author":"Klamerus","year":"1992","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib31","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/j.1552-4604.1997.tb04270.x","article-title":"Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxine","volume":"37","author":"Troy","year":"1997","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00007691-199606000-00014","article-title":"Automated determination of dextromethorphan and its main metabolites in human plasma by high performance-liquid chromatography and column switching","volume":"18","author":"H\u00e4rtter","year":"1996","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/clinchem\/44.5.914","article-title":"Ultrarapid drug metabolism: PCR-based detection of CYP2D6 gene duplication","volume":"44","author":"Steijns","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1067\/mcp.2002.127396","article-title":"Pharmacokinetics of Diltiazem and its metabolites in relation to CYP2D6 genotype","volume":"72","author":"Molden","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01.ftd.0000162868.84596.c3","article-title":"Metabolic ratios of psychotropics as indication of cytochrome P450 2D6\/2C19","volume":"27","author":"Van der Weide","year":"2005","journal-title":"Genotype. Ther. Drug Monit."},{"issue":"5","key":"10.1016\/j.clinbiochem.2009.04.009_bib36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2710.2006.00763.x","article-title":"CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine","volume":"31","author":"Shams","year":"2006","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib37","first-page":"889","article-title":"The human debrisoquine 4-hydroxylase (CYP2D6) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene","volume":"45","author":"Kimura","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib38","first-page":"373","article-title":"Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, frequencies and evolution","volume":"5","author":"Marez","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib39","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/clinchem\/48.9.1412","article-title":"Rapid and reliable method for cytochrome P450 2D6 genotyping","volume":"48","author":"Stamer","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.009_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1176\/appi.psy.47.1.75","article-title":"Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19","volume":"47","author":"Leon","year":"2006","journal-title":"Psychosomatics"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009001830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009001830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:30:42Z","timestamp":1757863842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912009001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0009912009001830"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.04.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or\/and duplication of the CYP2D6 gene","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}